Insider Transactions in Q4 2020 at Quanterix Corp (QTRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.89%
|
$71,681
$43.82 P/Share
|
|
Dec 18
2020
|
David C. Duffy SVP R&D and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+3.67%
|
$3,260
$2.28 P/Share
|
|
Dec 08
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.2%
|
$92,000
$46.98 P/Share
|
|
Dec 01
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,236
-0.16%
|
$139,148
$43.72 P/Share
|
|
Dec 01
2020
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
141
-0.22%
|
$6,063
$43.72 P/Share
|
|
Dec 01
2020
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
115
-0.22%
|
$4,945
$43.72 P/Share
|
|
Dec 01
2020
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
158
-0.25%
|
$6,794
$43.72 P/Share
|
|
Dec 01
2020
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
91
-0.21%
|
$3,913
$43.72 P/Share
|
|
Nov 24
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
2,070
+35.4%
|
-
|
|
Nov 24
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
454,434
-12.71%
|
-
|
|
Nov 24
2020
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
1,034
+7.96%
|
-
|
|
Nov 24
2020
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
454,434
-12.71%
|
-
|
|
Nov 20
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,707
+50.0%
|
-
|
|
Nov 20
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-9.49%
|
-
|
|
Nov 20
2020
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
854
+7.25%
|
-
|
|
Nov 20
2020
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-9.49%
|
-
|
|
Nov 19
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$88,000
$44.25 P/Share
|
|
Nov 16
2020
|
William Geist Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,045
+50.0%
|
-
|
|
Nov 12
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.89%
|
$81,683
$49.39 P/Share
|
|
Nov 12
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$98,000
$49.39 P/Share
|
|
Nov 05
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,372
-10.48%
|
$57,624
$42.45 P/Share
|
|
Nov 05
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,372
+9.49%
|
$2,744
$2.28 P/Share
|
|
Nov 04
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$62,400
$39.4 P/Share
|
|
Nov 04
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Nov 02
2020
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116
-0.46%
|
$4,176
$36.97 P/Share
|
|
Nov 02
2020
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
142
-0.45%
|
$5,112
$36.97 P/Share
|
|
Nov 02
2020
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
159
-0.5%
|
$5,724
$36.97 P/Share
|
|
Nov 02
2020
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
91
-0.43%
|
$3,276
$36.97 P/Share
|
|
Nov 02
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,264
-0.32%
|
$117,504
$36.97 P/Share
|
|
Oct 29
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$76,000
$38.3 P/Share
|
|
Oct 20
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$67,200
$42.57 P/Share
|
|
Oct 20
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 19
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$70,400
$44.59 P/Share
|
|
Oct 19
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 16
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.75%
|
$71,681
$43.04 P/Share
|
|
Oct 13
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$88,000
$44.49 P/Share
|
|
Oct 07
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$59,200
$37.17 P/Share
|
|
Oct 07
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 06
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$57,600
$36.47 P/Share
|
|
Oct 06
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 05
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$66,000
$33.9 P/Share
|
|
Oct 01
2020
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
288
+3.19%
|
$9,792
$34.7 P/Share
|
|
Oct 01
2020
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
396
+3.59%
|
$13,464
$34.7 P/Share
|
|
Oct 01
2020
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
520
+4.25%
|
$17,680
$34.7 P/Share
|
|
Oct 01
2020
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
338
+3.25%
|
$11,492
$34.7 P/Share
|
|
Oct 01
2020
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
159
-0.5%
|
$5,406
$34.12 P/Share
|
|
Oct 01
2020
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
143
-0.46%
|
$4,862
$34.12 P/Share
|
|
Oct 01
2020
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116
-0.46%
|
$3,944
$34.12 P/Share
|
|
Oct 01
2020
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
92
-0.43%
|
$3,128
$34.12 P/Share
|
|
Oct 01
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,286
-0.32%
|
$111,724
$34.12 P/Share
|